BRIEF-CTRL Group Limited Files For US IPO-March 2024-www.financetom.com

BRIEF-CTRL Group Limited Files For US IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-CTRL Group Limited Files For US IPO

Mar 15, 2024 12:36 PM

March 15 (Reuters) - CTRL Group Limited:

* CTRL GROUP LIMITED FILES FOR US IPO- SEC FILING

* CTRL GROUP LIMITED: HAVE APPLIED TO LIST ORDINARY SHARES

NASDAQ UNDER THE SYMBOL "MCTR"

* CTRL GROUP LTD - REVERE SECURITIES AND PACIFIC CENTURY

SECURITIES, LLC ARE UNDERWRITERS TO IPO

Source text for Eikon:

Further company coverage: [ ]

Previous page： Frontier Group Holdings Insider Sold Shares Worth $2,342,753, According to a Recent SEC Filing Next page： Boehringer to cap out-of-pocket inhaler cost at $35 per month

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Frontier Group Holdings Insider Sold Shares Worth $2,342,753, According to a Recent SEC Filing

Mar 7, 2024

07:30 AM EST, 03/07/2024 (MT Newswires) -- Barry Biffle, Director, CEO, around March 04, 2024, sold 308,774 shares in Frontier Group Holdings ( ULCC ) for $2,342,753. Following the Form 4 filing with the SEC, Biffle has control over a total of 821,930 shares of the company, with 772,981 shares held directly and 48,949 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1670076/000156218024002385/xslF345X03/primarydocument.xml...

Boehringer to cap out-of-pocket inhaler cost at $35 per month

Mar 7, 2024

March 7 (Reuters) - Boehringer Ingelheim will cap out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, the German drugmaker said on Thursday. The company said its new program will dramatically decrease costs at the pharmacy counter for patients, including those who are uninsured or underinsured. High healthcare...

EyePoint Pharmaceuticals' Q4 Net Loss Narrows, Revenue Advances; Shares Up Pre-Bell

Mar 7, 2024

07:33 AM EST, 03/07/2024 (MT Newswires) -- EyePoint Pharmaceuticals ( EYPT ) reported a Q4 net loss of $0.33 per diluted share, narrower than its loss of $1.16 a year earlier. Analysts polled by Capital IQ expected a loss of $0.49 per share. Revenue for the quarter ended Dec. 31 was $14 million, up from $10.5 million a year earlier....

NYCB total deposits drop 7% to $77.2 billion, shares fall

Mar 7, 2024

(Reuters) - New York Community Bancorp ( NYCB ) disclosed on Thursday it held deposits of $77.2 billion, down roughly 7% from the $83 billion it had on Feb. 5, sending its shares down 3.3% before the bell. The lender also said its strategic initiatives for the year include lowering its commercial real estate exposure. NYCB on Wednesday said it...